Healthcare News Pharma

Speaker Interview with Momchilo Vuyisich for MarketsandMarkets Gen-Next Probiotics and Microbiome Congress

https://events.marketsandmarkets.com/marketsandmarkets-gen-next-probiotics-and-microbiome-congress/

San Diego, December 12, 2019 – MarketsandMarkets recently interviewed Momchilo Vuyisich, Founder and Chief Science Officer, Viome, Inc regarding the MarketsandMarkets Gen-Next Probiotics and Microbiome Congress taking place on February 6-7, 2020 at Sheraton San Diego Hotel & Marina, San Diego.

Q. What is the real role of probiotics strains, prebiotics and symbiotic in influencing a health? What are the essentials being missed out on?

A. The field has focused on taxonomy and not functions of probiotics. We need to focus on probiotic colonization and expression of beneficial functions using appropriate prebiotics.

Q. What is your take on recent advances and future perspective in microbiota and probiotics?

A. We need many more strains of probiotics, as many people have poor gut microbiome richness

Momchilo Vuyisich will present on Viome’s systems biology platform for developing personalized nutrition algorithms based on molecular data at the congress.

The latest conference agenda and complete speaker line-up is available to download on the conference page, where you can also register – https://bit.ly/2si5Wwg

For more inquiries contact Suraj Waghmare, Marketing Executive on [email protected]

MarketsandMarkets Conferences

MarketsandMarkets Conferences

About Author

Leave a comment

Your email address will not be published.

You may also like

Pharma Top

CRISPR: An Emerging Technology for Genome Editing

CRISPR is an abbreviation of Clustered Regularly Interspaced Short Palindromic Repeats. In simpler words, it is a family of DNA
Pharma Top

Current Trends in Biomarker Research and Development

It is rightly said ‘Prevention is better than cure’, it is wise to stop something happening or detecting early and that’s